Skip to main content
SpringerLink
Log in

The first experience with the use of dapagliflozin in combination with ACEi for treatment of IgA nephropathy after kidney transplantation

  • Nephrology - Letter to the Editor
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Moroni G, Longhi S, Quaglini S et al (2013) The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Nephrol Dial Transplant 28(5):1305–1314

    Article  CAS  PubMed  Google Scholar 

  2. Ponticelli C, Glassock RJ (2010) Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol 5(12):2363–2372

    Article  PubMed  Google Scholar 

  3. Oka K, Imai E, Moriyama T et al (2000) A clinicopathological study of IgA nephropathy in renal transplant recipients: beneficial effect of angiotensin-converting enzyme inhibitor. Nephrol Dial Transplant 15(5):689–695

    Article  CAS  PubMed  Google Scholar 

  4. Wheeler DC, Toto RD, Stefánsson BV et al (2021) DAPA-CKD Trial Committees and Investigators. A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy. Kidney Int 100(1):215–224

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

There was no funding for this study.

Author information

Author notes

  1. Nikolina Basic-Jukic, Ivana Juric, Vesna Furic-Cunko and Lea Katalinic authors significantly contributed to the paper.

Authors and Affiliations

  1. Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, Clinical Hospital Centre Zagreb and School of Medicine, University of Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia

    Nikolina Basic-Jukic, Ivana Juric, Vesna Furic-Cunko & Lea Katalinic

Authors
  1. Nikolina Basic-Jukic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ivana Juric
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vesna Furic-Cunko
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lea Katalinic
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nikolina Basic-Jukic.

Ethics declarations

Conflict of interest

Authors have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Basic-Jukic, N., Juric, I., Furic-Cunko, V. et al. The first experience with the use of dapagliflozin in combination with ACEi for treatment of IgA nephropathy after kidney transplantation. Int Urol Nephrol 56, 811–812 (2024). https://doi.org/10.1007/s11255-023-03711-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-023-03711-0

Keywords

Search

Navigation